PeptiDream Management
Management criteria checks 2/4
PeptiDream's CEO is Patrick Crawford Reid, appointed in Sep 2017, has a tenure of 7.25 years. directly owns 3.28% of the company’s shares, worth ¥10.86B. The average tenure of the management team and the board of directors is 2.9 years and 9.3 years respectively.
Key information
Patrick Crawford Reid
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.3yrs |
| CEO ownership | 3.3% |
| Management average tenure | 2.9yrs |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
Are Investors Undervaluing PeptiDream Inc. (TSE:4587) By 39%?
Dec 22
PeptiDream's (TSE:4587) Performance Is Even Better Than Its Earnings Suggest
Nov 21PeptiDream Inc. Just Missed Earnings; Here's What Analysts Are Forecasting Now
Nov 18Is PeptiDream (TSE:4587) Using Too Much Debt?
Nov 15PeptiDream Inc.'s (TSE:4587) Price Is Out Of Tune With Earnings
Oct 31Do PeptiDream's (TSE:4587) Earnings Warrant Your Attention?
Oct 15PeptiDream Inc. (TSE:4587) Shares Could Be 37% Below Their Intrinsic Value Estimate
Aug 29PeptiDream Inc. Just Beat Revenue Estimates By 13%
Aug 12PeptiDream Inc. (TSE:4587) Surges 27% Yet Its Low P/S Is No Reason For Excitement
Jun 30News Flash: Analysts Just Made A Meaningful Upgrade To Their PeptiDream Inc. (TSE:4587) Forecasts
Jun 02PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues
Apr 30Is PeptiDream Inc. (TSE:4587) Trading At A 46% Discount?
Apr 29PeptiDream Inc.'s (TSE:4587) 25% Jump Shows Its Popularity With Investors
Mar 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | JP¥17b |
| Jun 30 2024 | n/a | n/a | JP¥22b |
| Mar 31 2024 | n/a | n/a | JP¥2b |
| Dec 31 2023 | n/a | n/a | JP¥3b |
| Sep 30 2023 | n/a | n/a | JP¥11b |
| Jun 30 2023 | n/a | n/a | JP¥8b |
| Mar 31 2023 | n/a | n/a | JP¥8b |
| Dec 31 2022 | JP¥180m | JP¥90m | JP¥8b |
Compensation vs Market: Insufficient data to establish whether Patrick Crawford's total compensation is reasonable compared to companies of similar size in the JP market.
Compensation vs Earnings: Insufficient data to compare Patrick Crawford's compensation with company performance.
CEO
Patrick Crawford Reid (49 yo)
7.3yrs
Tenure
JP¥179,999,000
Compensation
Dr. Patrick Crawford Reid, Ph.D. has been President of PeptiDream Inc. since September 2017 and serves as its CEO since January 2022. Dr. Reid served as Head of R&D and Senior Vice President at PeptiDream...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.3yrs | JP¥180.00m | 3.28% ¥ 10.8b | |
| CFO, Executive VP & Director | 2.9yrs | JP¥180.00m | 0.033% ¥ 110.2m | |
| COO, Executive VP & Director | 2.9yrs | JP¥180.00m | 0.041% ¥ 135.7m | |
| Chief Scientific Officer | less than a year | no data | no data | |
| IR & Public Relations Director | no data | no data | no data | |
| Chief Medical Officer | no data | no data | no data |
2.9yrs
Average Tenure
49yo
Average Age
Experienced Management: 4587's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 16.3yrs | JP¥180.00m | 3.28% ¥ 10.8b | |
| CFO, Executive VP & Director | 2.9yrs | JP¥180.00m | 0.033% ¥ 110.2m | |
| COO, Executive VP & Director | 9.9yrs | JP¥180.00m | 0.041% ¥ 135.7m | |
| Independent External Director | 9.3yrs | no data | 0.15% ¥ 510.2m | |
| Independent External Director | 8.8yrs | no data | no data | |
| Independent External Director | 9.3yrs | no data | 0.0059% ¥ 19.4m | |
| Independent External Director | 3.8yrs | no data | no data |
9.3yrs
Average Tenure
53yo
Average Age
Experienced Board: 4587's board of directors are considered experienced (9.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 15:19 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PeptiDream Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hidemaru Yamaguchi | Citigroup Inc |
| Fumiyoshi Sakai | Credit Suisse |
| Kazuaki Hashiguchi | Daiwa Securities Co. Ltd. |